1. Li, Man, Zeng, Jianmin, Chang, Yuhuan, Lv, Lili, Ye, Guoliu. . CCT3 as a Diagnostic and Prognostic Biomarker in Cervical Cancer. In Critical reviews in eukaryotic gene expression, 33, 17-28. doi:10.1615/CritRevEukaryotGeneExpr.2023048208. https://pubmed.ncbi.nlm.nih.gov/37522542/
2. Liu, Wenlou, Zhang, Xiuli, Chen, Cheng, Jiang, Guan, Liu, Yanqun. 2022. Suppression of CCT3 inhibits melanoma cell proliferation by downregulating CDK1 expression. In Journal of Cancer, 13, 1958-1971. doi:10.7150/jca.69497. https://pubmed.ncbi.nlm.nih.gov/35399722/
3. Søndergaard, Jonas Nørskov, Sommerauer, Christian, Atanasoai, Ionut, Barragan, Isabel, Kutter, Claudia. 2022. CCT3-LINC00326 axis regulates hepatocarcinogenic lipid metabolism. In Gut, 71, 2081-92. doi:10.1136/gutjnl-2021-325109. https://pubmed.ncbi.nlm.nih.gov/35022268/
4. Liu, Hua, Jiang, Yifan, Lu, Jiahua, Zheng, Shusen, Wu, Jian. . m6A-modification regulated circ-CCT3 acts as the sponge of miR-378a-3p to promote hepatocellular carcinoma progression. In Epigenetics, 18, 2204772. doi:10.1080/15592294.2023.2204772. https://pubmed.ncbi.nlm.nih.gov/37092305/
5. Luo, Lin, Xie, Qingzhi, Wu, Yunchou, Liao, Dunming, Wang, KangNing. 2023. Circular RNA CCT3 is a unique molecular marker in bladder cancer. In BMC cancer, 23, 977. doi:10.1186/s12885-023-11510-0. https://pubmed.ncbi.nlm.nih.gov/37833621/
6. Ma, Jingang, Song, Ping, Liu, Xinling, Lu, Zhong, Li, Jiaqiu. 2022. Insights into the roles and driving forces of CCT3 in human tumors. In Frontiers in pharmacology, 13, 1005855. doi:10.3389/fphar.2022.1005855. https://pubmed.ncbi.nlm.nih.gov/36313331/
智鼠故事 
